Defiance Autism Impact ETF (ASD)
- Open
- 28.263
- High
- 28.263
- Low
- 28.263
- Prev. Close
- 28.220
- Volume
- 42
- Turnover
- 1.20K
- Avg Price
- 28.643
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 28.520
- Volume Ratio
- 0.20
- Turnover Ratio
- --
News
- StockTitan · 8 hours ago
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union | ACAD Stock News
- Market Beat · 2 days ago, 02:20 AM
B. Metzler seel. Sohn & Co. AG Takes $3.60 Million Position in Repligen Corporation $RGEN
- PUBT · 2 days ago, 03:07 PM
Repligen CEO Olivier Loeillot disposes of 5,426 common shares worth $976,680
- Market Beat · 2 days ago, 04:12 AM
Mitsubishi UFJ Asset Management Co. Ltd. Purchases Shares of 148,853 Revvity Inc. $RVTY
- Fiercepharma · Aug 21 at 01:52 AM
Boehringer again rises up rare disease reputation rankings
- MarketWatch Automated · Aug 20 at 04:32 PM
Revvity Inc. Stock Outperforms Competitors On Strong Trading Day
